Clinical Trial Update: D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 clinical trial (D-SPARK) evaluating D-Serine for modifying progression in Parkinson's disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• D-serine (D-serine)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Parkinson s Disease, Parkinson Disease (PD) | Phase 2 | Status: RECRUITING